Glass House Brands Inc

Glass House Brands Inc(GLAS)股票分析

$2.460

-0.563 (-22.88%)收盤時

Loading chart…
最高
3.230
開盤
3.230
成交量加權均價
2.45
成交量
16.16M
市值
—
最低
1.670
成交金額
39.65M
企業價值/稅息折舊攤銷前利潤(TTM)
-1,548.81

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC).

AI 分析 of Glass House Brands Inc (GLAS)

賣出

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

估值指標

Glass House Brands Inc(GLAS)目前預期本益比為 31.45,5 年平均預期本益比為 167.23。

預期本益比

低估
5 年均值 P/E
167.23
目前P/E
31.45
高估
280.39
低估
54.08

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-2211.13
目前EV/EBITDA
-1548.81
高估
432.79
低估
-4855.05

預期股價營收比

嚴重低估
5 年均值 P/S
3.10
目前P/S
1.19
高估
3.82
低估
2.38

事件時間軸

2026-10-19 (ET)

09:00:00

Nasdaq Futures Rebound as Tech Stocks Recover

08:00:00

Glass House Reports Record Biomass Production of 317,000 Pounds in Q3

08:00:00

Glass House Sets FY26 Production Cost Target at $95

2026-10-14 (ET)

08:00:00

Glass House Achieves GACP Certification, Aiming for Medical Cannabis Exports

2026-09-29 (ET)

08:00:00

Glass House Brands CFO Mark Vendetti Plans Retirement

資訊

GLAS 常見問題 —— 由 Alphio AI 解答

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC). It operates in the Consumer Non-Cyclicals sector.

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易